Spreadex Market Update

Gains for Shire boost FTSE despite RSA collapse; Volkswagen deceit drags down DAX




The FTSE, somewhat against the odds, was up around 30 points at the open, lifted by a decent morning for its commodity stocks and a near 3% jump for Shire, which was just given permission by the European Commission to market its non-stimulant ADHD drug INTUNIV, already a major seller in the US, in Europe. However, despite a strong morning for the FTSE it wasn’t all good news for the index’s components, as RSA Insurance fell afoul of the curse of M&A, with Zurich Insurance dropping its takeover bid after it was forced to forecast a $200 million loss due to the Tianjin port explosions earlier in the year.

The Eurozone was more of a mixed bag; by and large the region opened with some decent gains, with the CAC up around 40 points at the open, following yet another Syriza victory in the Greek election that ostensibly secures the continued implementation of the measures agreed in the latest bailout.

The DAX, however, was the black sheep of the Eurozone, struggling to lift-off this Monday due to a mixture of worse than expected PPI data and, more importantly, a colossal 15% fall by Volkswagen after it admitted some rather naughty behaviour in regards to using software to produce false emission data in its diesel cars. With VW having to recall around half a million cars, something that could lead to a potential $18 million fine, investors fled the German giant, preventing the DAX from joining in with the morning fun in the process.


DISCLAIMER


Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 64% of retail investors lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money. For professional clients, spread betting and CFD trading can also result in losses larger than your initial stake or deposit.

Spreadex Ltd is authorised and regulated by the Financial Conduct Authority, provides an execution only service and does not provide advice in any way. Nothing within this update should be deemed to constitute the provision of investment advice, recommendations, any other professional advice in any way, or a record of our trading prices. This update does not constitute or form part of an offer of, or solicitation for a transaction in any financial instrument, nor shall it or the fact of its distribution form the basis of, or be relied on in connection with, any contract therefore. Any persons placing trades based on their interpretation of the comments or information within this update does so entirely at their own risk.

No representation, warranty, or undertaking, express or limited, is given as to the accuracy or completeness of the information or opinions contained within this update by Spreadex Ltd or any of its employees and no liability is accepted by such persons for the accuracy or completeness of any such information or opinions. As such, no reliance may be placed for any purpose on the information and opinions contained within this update.

The information contained within this update is the intellectual property of Spreadex Ltd and is protected by UK and International copyright laws. All rights reserved. Users may however freely download, distribute and reproduce extracts of the contents, subject always to accrediting Spreadex Ltd as the source and providing a hyperlink to www.spreadex.com.